Factors Affecting Compliance to Anti-Vascular Endothelial Growth Factor Treatment of Diabetic Macular Edema in a Cohort of Jordanian Patients

Nakhleh E Abu-Yaghi,1 Alaa M Abed,1 Dana F Khlaifat,2 Mohammed B Nawaiseh,2 Laith O Emoush,2 Heba Z AlHajjaj,2 Ala M Abojaradeh,2 Mariana N Hattar,2 Sura K Abusaleem,2 Hashem M Sabbagh,1 Yazan A Abu Gharbieh,1 Sura A Quaqazeh2 1Department of Special Surgery, Ophthalmology Division, The University of...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Abu-Yaghi NE, Abed AM, Khlaifat DF, Nawaiseh MB, Emoush LO, AlHajjaj HZ, Abojaradeh AM, Hattar MN, Abusaleem SK, Sabbagh HM, Abu Gharbieh YA, Quaqazeh SA
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2020
Materias:	diabetic macular edema anti-vascular endothelial growth factor retinopathy compliance Ophthalmology RE1-994
Acceso en línea:	https://doaj.org/article/ea483187438a4dae8d51d73b1b3354be
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:ea483187438a4dae8d51d73b1b3354be
record_format	dspace
spelling	oai:doaj.org-article:ea483187438a4dae8d51d73b1b3354be2021-12-02T11:37:59ZFactors Affecting Compliance to Anti-Vascular Endothelial Growth Factor Treatment of Diabetic Macular Edema in a Cohort of Jordanian Patients1177-5483https://doaj.org/article/ea483187438a4dae8d51d73b1b3354be2020-03-01T00:00:00Zhttps://www.dovepress.com/factors-affecting-compliance-to-anti-vascular-endothelial-growth-facto-peer-reviewed-article-OPTHhttps://doaj.org/toc/1177-5483Nakhleh E Abu-Yaghi,1 Alaa M Abed,1 Dana F Khlaifat,2 Mohammed B Nawaiseh,2 Laith O Emoush,2 Heba Z AlHajjaj,2 Ala M Abojaradeh,2 Mariana N Hattar,2 Sura K Abusaleem,2 Hashem M Sabbagh,1 Yazan A Abu Gharbieh,1 Sura A Quaqazeh2 1Department of Special Surgery, Ophthalmology Division, The University of Jordan, Amman, Jordan; 2School of Medicine, The University of Jordan, Amman, JordanCorrespondence: Nakhleh E Abu-YaghiThe University of Jordan, P.O. Box 7599, Amman 11118, JordanTel +962 798504937Email n.abuyaghi@ju.edu.joPurpose: To determine compliance rates and characteristics and to investigate factors affecting patients’ adherence to treatment with anti-vascular endothelial growth factors (anti-VEGFs) for diabetic macular edema (DME) in a cohort of Jordanian patients.Methods: A retrospective case series wherein the files of DME patients treated with anti-VEGFs were reviewed and analyzed for factors affecting treatment compliance was undertaken. Demographic, clinical and ocular characteristics were recorded. All patients were also interviewed by phone using a structured questionnaire. Univariate and multivariate analyses were performed to determine factors associated with compliance.Results: A total of 117 patients (65 males 52 females) were included in this study with a mean age of 62.93 years (± 9.75). Approximately, 85% of patients were compliant to their treatment and follow-up plan during the first year of management. Subjective perception of visual improvement after receiving three loading doses was the only independent variable with a unique statistically significant contribution to compliance. All other studied factors in this group of patients were not significantly associated with patient compliance.Conclusion: VEGF suppression via the intravitreal route to treat DME is a long-term process that requires caregiver dedication but also proper patient compliance. Addressing real-life barriers in those patients may help guide future strategies to improve the treatment experience, lower the financial burden and contribute to better outcomes. Patients’ perceptions of possible treatment outcomes at the short term may influence their long-term commitment to therapy.Keywords: diabetic macular edema, anti-vascular endothelial growth factor, retinopathy, compliance  Abu-Yaghi NEAbed AMKhlaifat DFNawaiseh MBEmoush LOAlHajjaj HZAbojaradeh AMHattar MNAbusaleem SKSabbagh HMAbu Gharbieh YAQuaqazeh SADove Medical Pressarticlediabetic macular edemaanti-vascular endothelial growth factorretinopathycomplianceOphthalmologyRE1-994ENClinical Ophthalmology, Vol Volume 14, Pp 921-929 (2020)
institution	DOAJ
collection	DOAJ
language	EN
topic	diabetic macular edema anti-vascular endothelial growth factor retinopathy compliance Ophthalmology RE1-994
spellingShingle	diabetic macular edema anti-vascular endothelial growth factor retinopathy compliance Ophthalmology RE1-994 Abu-Yaghi NE Abed AM Khlaifat DF Nawaiseh MB Emoush LO AlHajjaj HZ Abojaradeh AM Hattar MN Abusaleem SK Sabbagh HM Abu Gharbieh YA Quaqazeh SA Factors Affecting Compliance to Anti-Vascular Endothelial Growth Factor Treatment of Diabetic Macular Edema in a Cohort of Jordanian Patients
description	Nakhleh E Abu-Yaghi,1 Alaa M Abed,1 Dana F Khlaifat,2 Mohammed B Nawaiseh,2 Laith O Emoush,2 Heba Z AlHajjaj,2 Ala M Abojaradeh,2 Mariana N Hattar,2 Sura K Abusaleem,2 Hashem M Sabbagh,1 Yazan A Abu Gharbieh,1 Sura A Quaqazeh2 1Department of Special Surgery, Ophthalmology Division, The University of Jordan, Amman, Jordan; 2School of Medicine, The University of Jordan, Amman, JordanCorrespondence: Nakhleh E Abu-YaghiThe University of Jordan, P.O. Box 7599, Amman 11118, JordanTel +962 798504937Email n.abuyaghi@ju.edu.joPurpose: To determine compliance rates and characteristics and to investigate factors affecting patients’ adherence to treatment with anti-vascular endothelial growth factors (anti-VEGFs) for diabetic macular edema (DME) in a cohort of Jordanian patients.Methods: A retrospective case series wherein the files of DME patients treated with anti-VEGFs were reviewed and analyzed for factors affecting treatment compliance was undertaken. Demographic, clinical and ocular characteristics were recorded. All patients were also interviewed by phone using a structured questionnaire. Univariate and multivariate analyses were performed to determine factors associated with compliance.Results: A total of 117 patients (65 males 52 females) were included in this study with a mean age of 62.93 years (± 9.75). Approximately, 85% of patients were compliant to their treatment and follow-up plan during the first year of management. Subjective perception of visual improvement after receiving three loading doses was the only independent variable with a unique statistically significant contribution to compliance. All other studied factors in this group of patients were not significantly associated with patient compliance.Conclusion: VEGF suppression via the intravitreal route to treat DME is a long-term process that requires caregiver dedication but also proper patient compliance. Addressing real-life barriers in those patients may help guide future strategies to improve the treatment experience, lower the financial burden and contribute to better outcomes. Patients’ perceptions of possible treatment outcomes at the short term may influence their long-term commitment to therapy.Keywords: diabetic macular edema, anti-vascular endothelial growth factor, retinopathy, compliance
format	article
author	Abu-Yaghi NE Abed AM Khlaifat DF Nawaiseh MB Emoush LO AlHajjaj HZ Abojaradeh AM Hattar MN Abusaleem SK Sabbagh HM Abu Gharbieh YA Quaqazeh SA
author_facet	Abu-Yaghi NE Abed AM Khlaifat DF Nawaiseh MB Emoush LO AlHajjaj HZ Abojaradeh AM Hattar MN Abusaleem SK Sabbagh HM Abu Gharbieh YA Quaqazeh SA
author_sort	Abu-Yaghi NE
title	Factors Affecting Compliance to Anti-Vascular Endothelial Growth Factor Treatment of Diabetic Macular Edema in a Cohort of Jordanian Patients
title_short	Factors Affecting Compliance to Anti-Vascular Endothelial Growth Factor Treatment of Diabetic Macular Edema in a Cohort of Jordanian Patients
title_full	Factors Affecting Compliance to Anti-Vascular Endothelial Growth Factor Treatment of Diabetic Macular Edema in a Cohort of Jordanian Patients
title_fullStr	Factors Affecting Compliance to Anti-Vascular Endothelial Growth Factor Treatment of Diabetic Macular Edema in a Cohort of Jordanian Patients
title_full_unstemmed	Factors Affecting Compliance to Anti-Vascular Endothelial Growth Factor Treatment of Diabetic Macular Edema in a Cohort of Jordanian Patients
title_sort	factors affecting compliance to anti-vascular endothelial growth factor treatment of diabetic macular edema in a cohort of jordanian patients
publisher	Dove Medical Press
publishDate	2020
url	https://doaj.org/article/ea483187438a4dae8d51d73b1b3354be
work_keys_str_mv	AT abuyaghine factorsaffectingcompliancetoantivascularendothelialgrowthfactortreatmentofdiabeticmacularedemainacohortofjordanianpatients AT abedam factorsaffectingcompliancetoantivascularendothelialgrowthfactortreatmentofdiabeticmacularedemainacohortofjordanianpatients AT khlaifatdf factorsaffectingcompliancetoantivascularendothelialgrowthfactortreatmentofdiabeticmacularedemainacohortofjordanianpatients AT nawaisehmb factorsaffectingcompliancetoantivascularendothelialgrowthfactortreatmentofdiabeticmacularedemainacohortofjordanianpatients AT emoushlo factorsaffectingcompliancetoantivascularendothelialgrowthfactortreatmentofdiabeticmacularedemainacohortofjordanianpatients AT alhajjajhz factorsaffectingcompliancetoantivascularendothelialgrowthfactortreatmentofdiabeticmacularedemainacohortofjordanianpatients AT abojaradeham factorsaffectingcompliancetoantivascularendothelialgrowthfactortreatmentofdiabeticmacularedemainacohortofjordanianpatients AT hattarmn factorsaffectingcompliancetoantivascularendothelialgrowthfactortreatmentofdiabeticmacularedemainacohortofjordanianpatients AT abusaleemsk factorsaffectingcompliancetoantivascularendothelialgrowthfactortreatmentofdiabeticmacularedemainacohortofjordanianpatients AT sabbaghhm factorsaffectingcompliancetoantivascularendothelialgrowthfactortreatmentofdiabeticmacularedemainacohortofjordanianpatients AT abugharbiehya factorsaffectingcompliancetoantivascularendothelialgrowthfactortreatmentofdiabeticmacularedemainacohortofjordanianpatients AT quaqazehsa factorsaffectingcompliancetoantivascularendothelialgrowthfactortreatmentofdiabeticmacularedemainacohortofjordanianpatients
_version_	1718395796159725568

Factors Affecting Compliance to Anti-Vascular Endothelial Growth Factor Treatment of Diabetic Macular Edema in a Cohort of Jordanian Patients

Ejemplares similares